Skip to main content
. 2019 Mar 21;17(6):4835–4842. doi: 10.3892/ol.2019.10175

Figure 1.

Figure 1.

Expression of talin2 in MDA-MB-231 cells and breast cancer tissues. (A) Distribution of talin2 expression in tumor tissues and normal tissues based on IHC (magnification, ×400). (B) Semi-quantification of IHC results. ***P<0.001 compared with normal tissues. (C) Endogenous talin2 protein levels in talin2-depleted and control MDA-MB-231 cells, as measured by western blotting. (D) Relative mRNA expression levels of talin2 in talin2-depleted and control MDA-MB-231 cells, as measured by quantitative polymerase chain reaction. **P<0.01, ***P<0.001 compared with shRNA cntl. cntl, control; IHC, immunohistochemistry; shRNA, short hairpin RNA.